Sproutys and Sprouty-related proteins, Spred-1 and -2, are known inhibitors of fibroblast growth factor (FGF) signaling, which plays key role in lung branching morphogenesis and the development of other tissues. The present study demonstrates that Spreds are expressed in a variety of rat embryonic tissues (brain, intestine, heart, skin) including the lung. In the embryonic lung, Spreds and Sproutys are expressed during the early stages of branching morphogenesis, but their expression profiles are both distinct and overlapping. Spreds are predominantly expressed in mesenchymal cells in contrast to Sproutys, which are abundantly expressed in epithelial cells. Spred expression is especially strong in the regions of new bud formation both in the peripheral mesenchyme as well as in the epithelium. The peripheral region also expresses FGF-10 in the mesenchymal cells and FGF-9 in the mesothelial cells. The expression profiles suggest that Spreds, Sproutys and FGF-9/FGF-10 are part of epithelial-mesenchymal interactions, which are essential for the development and maintenance of normal lung branching pattern. q
Introduction
Abundant evidence indicates that signaling by keratinocyte growth factor receptor (KGFR or FGFR2IIIb), a member of the fibroblast growth factor receptor (FGFR) family of tyrosine kinases, regulates epithelial branching and differentiation in the mammalian lung. Evidence supporting a crucial role of KGFR in these processes has been obtained from transgenic studies. Pulmonary overexpression of dominant negative KGFR in transgenic mice resulted in severe inhibition of branching in the lung (Peters et al., 1994) . For the lung development, the main KGFR ligand appears to be FGF-10 and not KGF. While a lung phenotype was absent in KGF knockout mice (Guo et al., 1996) , the FGF-10 knockout animals showed complete lack of lung development (Min et al., 1998; Sekine et al., 1999) . Other evidence also suggests that FGF-10 is indeed a key player in lung branching morphogenesis. FGF-10 is produced by the peripheral mesenchymal cells and acts on distal bud epithelium as a chemoattractant (Bellusci et al., 1997; Park et al., 1998) . The region of FGF-10 expression overlaps the region of new bud formation (Bellusci et al., 1997) . Another FGF family member, FGF-9, is produced by mesothelial cells and also regulates branching morphogenesis. FGF-9-null-mice exhibit reduced mesenchyme and decreased branching of the airways. The signaling cascade activated by FGF-9/FGF-10, similar to other ligands of receptor tyrosine kinases, involves Raf, MAP ERK kinase (MEK), and extracellular-regulated kinases (ERK) 1 and 2 as signal transducers. Thus the effects of FGF-9/FGF10 on branching morphogenesis must be mediated by the activation of the MAP kinase pathway. Indeed, MEK inhibition has been shown to reduce lung branching (Kling et al., 2002) . Several additional proteins have been identified recently that act as inhibitors of the MAP kinase pathway and may play roles in branching morphogenesis. Sproutys (Sprouty-1, -2, -4) act as suppressors of Ras-MAP kinase signaling (Hacohen et al., 1998; Reich et al., 1999; Kramer et al., 1999) . Sprouty-2 has been shown to regulate lung branching morphogenesis (Tefft et al., 1999) . Addition of antisense Sprouty oligonucleotide to mouse lung explant cultures increased branching (Tefft et al., 1999) . A probable mechanism of Sprouty-2 inhibition of lung branching could involve its inhibition of the FGF-10 signaling. Wakioka and coworkers ) have identified two Sprouty-related, EVH-1 domain containing proteins, Spred-1 and Spred-2. Spreds at their N-terminal contains the EVH-1 domain and a conserved cysteine-rich domain similar to Sprouty proteins. Spred-like Sprouty has been shown to inhibit growth factor-induced downstream signaling and may perform at least some functions similar to Sproutys Sasaki et al., 2001) . To gain insights into their potential roles, it was deemed essential to compare the expression patterns of Sproutys (Sprouty-1 and -2) and Spreds (Spred-1 and -2) in rat lungs during development. In the present study we report that Sproutys and Spreds are all expressed in the lung from the onset of branching morphogenesis. Their expression profiles are both distinct and overlapping. Spreds are predominantly expressed in mesenchymal tissue, in contrast to Sproutys, which are abundantly expressed in epithelial cells. While high levels of Sprouty-1 and -2 expression persist in the adult lung, Spred-1 expression is considerably diminished. Additionally, Spreds, like Sproutys, are expressed in a variety of other embryonic tissues (brain, heart, intestine, skin).
Results and discussion

Gene expression in embryonic and adult rat lungs
The developmental gene expression of Sproutys and Spreds was examined by reverse transcription-polymerase chain reaction (RT-PCR) using lungs obtained from embryonic day-16 (E16) rat embryos and adult rats (Fig.  1) . The PCR products were of the predicted sizes as revealed by agarose gel electrophoresis (Fig. 1) . While the expression of Sprouty-1 and Spred-2 in embryonic and adult rat lungs was similar, Spred-1 and Sprouty-2 expression was lower in the adult lungs (as assessed by the amplification at 25 and 30 cycles).
Embryonic gene expression patterns
Sprouty-1 and -2 expression in different organs of early mouse embryos has been described by other investigators (Minowada et al., 1999; Zhang et al., 2001) . Here, we present the localization of Spred-1 and -2 in rat embryos (E14) by in situ hybridization (ISH). In the E14 embryos, both Spred-1 and -2 transcripts were expressed in the brain tissues (telencephalon, mesencephalon, and rhombencephalon), spinal cord, heart, intestine, and skin (Fig. 2) . However, Spred-2 mRNA expression was particularly strong in cells of the ventricular layer (Fig. 2 , arrowhead in f) and in head mesenchyme (Fig. 2b,h ). No apparent expression of Spred-1 or -2 was noted in the liver (Fig. 2a,b) .
Next we studied gene expression in E14 and E16 lungs. In the E14 lungs, SP-C, a marker of distal epithelium, was expressed in epithelium of distal tubules (Fig. 3, arrows in b, d) . At this stage, CC10, a marker of proximal epithelium, was not detected both in the proximal or the distal tubules (Fig. 3a,c) . Sprouty-1 transcripts were predominantly expressed in the mesenchymal cells adjacent to the epithelial tubules (Fig. 3 , arrowheads in e), whereas Sprouty-2 mRNA was highly expressed in the epithelium of distal tubules (Fig. 3 , arrows in f). Spred-1 and Spred-2 mRNA expression was particularly strong in the peripheral mesenchymal cells (Fig. 3 , arrowheads in g,h). In agreement with the previous reports (Bellusci et al., 1997; Mailleux et al., 2001 ), FGF-10 was also expressed in the peripheral mesenchymal cells (Fig. 3 , arrowheads in i).
In the E16 lungs, somewhat distinct patterns of CC10 and SP-C mRNA expression were observed. CC-10 was more abundantly expressed in the proximal tubules than in the distal tubules (Fig. 4a) , whereas SP-C expression was limited to the distal tubules (Fig. 4b) . Sprouty-1 expression was observed in the mesenchymal cells surrounding the epithelial tubules ( Fig. 4c and arrowheads in d) as well as in the epithelial cells lining the distal tubules (Fig. 4 , arrows in c). While the epithelial cells at the tips of distal tubules showed high Sprouty-2 expression (Fig. 4, arrows in e) , the epithelial cells lining the clefts between buds lacked Spro- uty-2 expression (Fig. 4 , arrowhead in e), an observation previously reported by Mailleux et al., 2001 . Spred-1 (Fig.  4 , arrow and arrowheads in f,g), Spred-2 (Fig. 4 , arrow and arrowheads in h) and FGF-10 (Fig. 4 , arrowheads in i and j) expression patterns were similar to those seen in the E14 lungs. However, Spred-1 and -2 expression was also observed in the epithelial cells lining the distal tubules (Fig. 4, arrows in g,h) .
A culture system was used to study the gene expression patterns in relation to lung branching. E14 lungs undergo repetitive branching when cultured in a suitable medium (Shiratori et al., 1996) . E14 lung demonstrates CC10 ( Fig.  5a and arrows in c) and SP-C ( (Fig.  5, arrowheads in c) . Sprouty-1 and -2 transcripts were found in the epithelium of newly-formed buds (Fig. 5 , arrows in e and g). Sprouty-1 expression was also remarkable in the mesenchymal cells adjacent to the epithelial tubules (Fig.   5 , arrowheads in f). In contrast, Sprouty-2 transcripts were barely detectable in the mesenchymal cells (Fig. 5h) . Spred-1 mRNA, on the other hand, was strongly expressed in the mesenchymal cells (Fig. 5 , arrowheads in i,j) as well as in the epithelium of distal tubules (Fig. 5, arrows in i) . The pattern of Spred-2 expression was similar to that of Spred-1 (data not shown). FGF-10 was exclusively expressed in the mesenchymal cells, especially those at the periphery of the lung (Fig. 5, arrowheads in k) .
The expression pattern of Sprouty-2 in embryonic lung was similar to that reported by other investigators (Mailleux et al., 2001; Zhang et al., 2001 ). While Sprouty-1 expression pattern in epithelial cells was similar to that reported by Zhang et al. (2001) , the expression pattern in mesenchymal cells differed. We observed that Sprouty-1 transcripts were abundantly expressed in the mesenchymal cells surrounding epithelial tubules. In the study by Zhang et al. using cultured embryonic mouse lungs, Sprouty-1 transcripts were not found in any mesenchymal cell population (Zhang et al., 2001) . Magnified views of these sections are shown in (c-p): brain (c-h), spinal cord (i-l), heart (m,n), and intestine (o,p). Skin (f, arrows), head mesenchyme (h, *5) and ventricular layer (e, *2; f, arrowhead) strongly express Spred-2. *1, telencephalon; *2, ventricular layer; *3, mesencephalon; *4, rhombencephalon; *5, head mesenchyme; *6, spinal cord; *7, heart; *8, intestine; *9, liver. Bars: a; b ¼ 1 mm; c-P ¼ 100 mm. Fig. 3 . Localization of CC10, SP-C, Sprouty-1, Sprouty-2, Spred-1, Spred-2 and FGF-10 in E14 rat lungs by ISH. SP-C expression is particularly strong at the tip of the distal tubules (b,d), whereas CC10 expression is not observed at this stage of lung development (a,c). Sprouty-1 is expressed in mesenchymal cells surrounding the epithelial tubules (arrowheads in e). In contrast, Sprouty-2 expression is mainly seen in epithelium of the distal tubules (arrows in f). Spred-1 and Spred-2 transcripts are mainly observed in the peripheral mesenchymal cells (arrowheads in g,h), a population of cells that also expresses FGF-10 (arrowheads in i). Bar: 100 mm. Fig. 4 . Localization of CC10, SP-C, Sprouty-1, Sprouty-2, Spred-1, Spred-2, and FGF-10 in E16 lungs by ISH. SP-C is exclusively expressed in the distal epithelium (b), whereas strong CC10 expression is seen in the proximal epithelium (a). In distal tubules, CC10 expression is negligible or absent (a). Sprouty-1, Sprouty-2, Spred-1, Spred-2, and FGF-10 expression patterns are to a large extent similar to those seen in E14 lungs (Fig. 3) . Sprouty-1 (arrows in c), Sprouty-2 (arrows in e), Spred-1 (arrow in g) and Spred-2 (arrow in h) are all expressed in distal bud epithelium. Additionally, Sprouty-2 expression in cleft epithelium is lacking (arrowhead in e). FGF-10 transcripts are seen in the peripheral mesenchyme (arrowheads in i,j), a region in which Spred-1 (arrowheads in f,g) and Spred-2 (arrowheads in h) are strongly expressed. As in E14 lung (Fig. 3) , E16 lung shows strong Sprouty-1 expression in the mesenchymal cells adjacent to the epithelial tubules (arrowheads in d). Bar: 100 mm.
Expression patterns in the adult lung
CC10 and SP-C mRNA expression patterns in the adult lung are shown in Fig. 6 . SP-C was expressed exclusively in alveolar epithelial type II cells (Fig. 6b) , whereas CC10 expression was observed in the bronchiolar epithelium as well as in the alveolar epithelial type II cells (Fig. 6a) . Non-ciliated bronchiolar epithelial cells (Clara cells) (Fig.  6 , arrows in c) and alveolar epithelial type I (Fig. 6 , arrowhead in d) and type II cells (Fig. 6, arrow in d) showed Sprouty-1 expression. The same cell-types expressed Sprouty-2, although a smaller number of cells showed detectable expression than those expressing Sprouty-1 (Fig. 6e,f) . Spred-1 transcripts were noted in a few bronchiolar (Fig. 6 , arrow in g) and alveolar epithelial cells (arrow in h) as well as in the interstitial cells (Fig. 6, arrowhead in i) . Spred-1 mRNA was also found in a few endothelial cells (Fig. 6 , arrowhead in h). Spred-1 expression was found to be lower in the adult lung (Fig. 6g-i ) than in fetal lung (Fig. 4f,g ) by ISH analysis, confirming the results from RT-PCR analysis (Fig. 1) .
What roles Sproutys and Spreds play in regulating branching morphogenesis and epithelial/mesenchymal growth and differentiation remain to be investigated. There is some evidence suggesting that Sprouty-2 is a regulator of lung branching morphogenesis (Tefft et al., 1999) .
However, potential roles of Sprouty-1 and Spreds, which are also expressed from the early stages of branching morphogenesis, have not been determined. The high Spred-1 and Spred-2 expression in the peripheral mesenchyme may be in response to the FGF-9 expressed by the mesothelial cells. That FGF-9 plays a role in lung branching morphogenesis has been clearly demonstrated in studies on FGF-9-null mice. FGF-9 2 /2 mice exhibited reduced mesenchyme and decreased branching of the airways (Colvin et al., 2001) . Thus, Sproutys, Spreds, FGF-9, and FGF-10 may be part of epithelial-mesenchymal interactions, which are essential for the development and maintenance of normal lung branching pattern.
Experimental procedures
Tissues
Timed pregnant rats of the Sprague-Dawley strain were obtained from Hilltop (Scottsdale, PA). Whole rat embryos and lungs from embryonic and adult rats were fixed overnight in 4% paraformaldehyde solution at 4 8C, embedded in OCT compound and frozen at 280 8C. E14 lungs were cultured for 4 days in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, streptomycin/penicillin G (0.1 mg/ml), gentamicin (10 mg/ml), fungizone (2.5 mg/ ml), and heparin (30 mg/ml) (Shiratori et al., 1996) .
RT-PCR
Total RNA extracted from adult and embryonic (E16) rat lungs was subjected to RT-PCR according to a described protocol (Shiratori et al., 1996) . The nucleotide sequences of the sense and antisense primers are shown in Table 1 . The samples were amplified for 25 and 30 cycles, each consisting of: annealing for 1 min, elongation at 72 8C for 3 min, and denaturation at 95 8C for 40 s. Identity of each PCR product was confirmed by nucleotide sequencing. 
Labeled probes
Digoxigenin-labeled antisense and sense riboprobes were generated from the RT-PCR products tagged with T7-RNA polymerase recognition site. A labeling kit from Roche (Indianapolis, IN) was used to generate Digoxigenin-labeled riboprobes. For in situ hybridization, each probe was used at 400 ng/ml.
In situ hybridization (ISH)
Frozen sections (8 mm thick) on silylated slides were fixed with 4% paraformaldehyde. After blocking the endogenous peroxidase with 0.3% H 2 O 2 in methanol for 30 min and alkaline phosphatase with 0.2 N HCl for 5 min, the sections were digested with 0.016% pepsin for 5 min at 37 8C. After acetylation and prehybridization, the sections were hybridized with each DIG-labeled antisense and sense (for control) probe. All subsequent steps of signal amplification by the DNP Plus Tyramide System (NEN Life Science, Boston MA) were carried out at room temperature. After hybridization, the slides were treated with HRP-anti-DIG antibody for 45 min followed by DNP-Tyramide for 8 min. The DNP complexes were amplified with HRP-anti-DNP antibody for 30 min followed by DNP-Tyramide for 8 min, and finally reacted with alkaline phosphatase (AP)-anti-DNP antibody. The AP complexes were visualized by reaction with an AP substrate, Fast Red. After counterstaining with Mayer's hematoxylin, the sections were mounted in a SuperMount permanent aqueous mounting medium (BioGenex, San Ramon, CA) and coverslipped.
